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ABSTRACT  The emergence of specialized cell types and their organisation into organs and
tissues involve the temporal modulation of many genes that are essential for coordinating the
correct timing of instructive signals. These transcriptional changes are orchestrated with a
precision that reminds that of a classical symphony. Extracellular signals are transmitted to key
«integrators», which then orchestrate activation or repression of specific genes. In the last decade,
class IIa HDACs have emerged as crucial regulators in various developmental and differentiation
processes. This review focuses on the latest studies that have provided new insights into the
biological functions of class IIa HDACs and discusses important aspects of their regulation.
Elucidating cellular and molecular mechanisms by which functions of class IIa HDACs are
modulated could potentially lead to new therapeutic opportunities for various diseases.
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The classification of the eighteen human Histone Deacetylases
(HDACs) identified to date relies on biochemical, structural and
phylogenetic criteria. Based on their dependence on specific co-
factors, a first division separates group I HDACs, which are zinc-
dependent amidohydrolases, from group II enzymes (also known
as class III HDACs or SIRTs), which rely on nicotinamide adenine
dinucleotide (NAD) for their catalytic activity (Haigis and Guarente,
2006). Group I HDACs are further subdivided into classes I, II and
IV, based on their similarity to yeast proteins (Yang and Seto,
2008). While class I HDACs (HDAC1,-2,-3 and -8) are related to
the yeast transcriptional regulator Rpd3 (Rundlett et al., 1996;
Taunton et al., 1996), class II enzymes (HDAC4,-5,-6,-7,-9,-10)
show more similarity to yHDA1, a Rpd3-paralog (Fischer et al.,
2002; Fischle et al., 2001; Fischle et al., 1999; Grozinger et al.,
1999; Guardiola and Yao, 2002; Kao et al., 2000; Miska et al.,
1999; Petrie et al., 2003; Tong et al., 2002; Verdel and Khochbin,
1999; Wang et al., 1999; Zhou et al., 2001; Zhou et al., 2000a).
Careful phylogenetic analyses have singled HDAC11 out from
other group I HDACs and led to the idea that it might be the
defining member of a separate fourth class (Gregoretti et al.,
2004).
Based on their structure, class II HDACs are further divided
into two subclasses: class IIa (HDAC4, -5, -7 and -9) and class IIb
(HDAC6 and -10) (Verdin et al., 2003). Class IIa HDACs are the
subject of this review and show a very specific structural organi-
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zation, that includes two distinct domains. The catalytic HDAC
domain lies within the C-terminal half of the protein and corre-
sponds to the HDA1-like sequences. The N-terminal part of class
IIa HDACs is the hallmark of the subfamily and contains specific
conserved amino acid motifs that are specialized for binding an
array of proteins, such as DNA-binding transcription factors,
transcriptional corepressors and chaperone proteins (Martin et
al., 2007). This adaptor domain of class IIa HDACs also contains
several motifs specifically involved in their regulation. A canonical
nuclear localization signal is found in the N-terminus of all class
IIa members and controls their subcellular localization (McKinsey
et al., 2000a; McKinsey et al., 2001; Wang and Yang, 2001). In
addition, several conserved residues are targeted by various
post-translational modifications, such as ubiquitination (Li et al.,
2004), sumoylation (Kirsh et al., 2002; Petrie et al., 2003),
phosphorylation (Grozinger and Schreiber, 2000; Wang et al.,
2000) and proteolytic cleavage (Bakin and Jung, 2004; Li et al.,
2004; Paroni et al., 2004; Scott et al., 2008).
According to the current view, class IIa HDACs are thought to
act as transcriptional co-repressors by deacetylating nucleoso-
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mal histones in the vicinity of target promoters. Since class IIa
HDACs do not bind to DNA, their repressive activity relies on
interactions with sequence-specific DNA binding proteins, which
thus dictate the targeting specificity of class IIa HDACs. The
canonical example of this model is illustrated by the interaction
between class IIa HDACs and myocyte enhancer factor 2 (MEF2)
transcription factors (Martin et al., 2007). However, this simplistic
model is challenged by a series of experimental evidence. It is
notorious that compared to class I or class IIb, class IIa HDACs
are very inefficient histone deacetylases (Fischle et al., 2002;
Fischle et al., 1999; Hassig et al., 1998; Hu et al., 2000). An
explanation for this intrinsic weak HDAC activity came from a
recent study showing that, in place of a catalytic tyrosine residue
that is strictly conserved in other group I enzymes, class IIa
HDACs have an histidine that compromises their activity towards
acetyl-lysines (Lahm, 2007). Very importantly, these findings
raise the intriguing possibility that class IIa HDACs might in fact
not target acetylated proteins, but still-to-be-discovered sub-
strates. In addition, class IIa HDACs can repress transcription
independently of their C-terminal catalytic domain, which sug-
gests that at least part of their repressive properties does not rely
on deacetylation of proximal histones (Kao et al., 2000; Lemercier
et al., 2000; Sparrow et al., 1999; Wang et al., 1999; Zhou et al.,
2000a). Indeed, the isolated N-terminal region of class IIa HDACs
can repress transcription by recruiting co-repressors, such as
HP1 or CtBP (Zhang et al., 2002; Zhang et al., 2001a; Zhang et
al., 2001b). Finally, class IIa HDACs can also modulate the
transcriptional activity of their partners by regulating specific post-
transcriptional modifications, such as sumoylation (Gregoire et
al., 2006; Gregoire and Yang, 2005; Zhao et al., 2005) or
ubiquitination (Jeon et al., 2006; Jin et al., 2004).
In addition to their similar structural organization, class IIa
HDACs also share the same overall mechanism of regulation.
Regulation of class IIa members relies on their ability to shuttle
between the nucleus and the cytoplasm, in response to specific
extracellular signals (Martin et al., 2007). When in the nucleus,
class IIa HDACs can partner with transcription factors and co-
repressors to inhibit transcription. In contrast, cytoplasmic accu-
mulation of class IIa HDACs makes them unable to impact on
transcription as it sequesters them away from histones and
renders them enzymatically inactive as histone deacetylases
(Fischle et al., 2001; Fischle et al., 2002). Multiple lines of
evidence suggest that class IIa HDAC subcellular localization
relies on the phosphorylation of several conserved serine resi-
dues located in their adaptor domain. When phosphorylated,
these residues are targeted for binding by 14-3-3 proteins, which
promote CRM1-dependent nuclear export and /or cytoplasmic
sequestration of class IIa HDACs (Grozinger and Schreiber,
2000; Kao et al., 2001; Liu et al., 2005; Wang et al., 2000). In
contrast, mutation of the phosphorylatable residues into alanine
generates shuttling deficient class IIa HDACs and abolishes the
signal-responsiveness of their target genes (Dequiedt et al.,
2003; Ha et al., 2008; McKinsey et al., 2000a; Miska et al., 2001;
Wang et al., 2008; Zhang et al., 2002; Zhang et al., 2001b). As
described for several of their target proteins, 14-3-3 are thought
to directly control the subcellular localization of class IIa HDACs
by modulating the function of their NES and NLS (Grozinger and
Schreiber, 2000; McKinsey et al., 2000a; Muslin and Xing, 2000).
However, a series of important observations have been over-
looked that are not compatible with this model. First, despite
having intact 14-3-3 binding sites, HDAC5 mutants harboring
inactivating mutations in their NES remain nuclear. But most
importantly, the constitutive nuclear localization of these NES
mutants does not increase their repressive activity. This indicates
that release from their targeting DNA-binding partners, rather
than exit from the nucleus is the crucial step in the relief of class
IIa HDAC transcriptional repression by phosphorylation (Lu et al.,
2000a; McKinsey et al., 2000a). In this context, 14-3-3-dependent
nuclear export of class IIa HDACs may only serve as a supporting
mechanism that ensures maximal activation of their target genes
(McKinsey et al., 2000a). In addition, some data suggest that
association with 14-3-3 could be dispensable for CRM1-mediated
nuclear export of class IIa HDACs (Gao et al., 2006). Full compre-
hension of the complex mechanisms governing class IIa HDAC
subcellular localisation and activity undoubtedly requires further
investigation in order to solve these important issues.
As described above, inhibition of class IIa HDAC phosphoryla-
tion by serine-to-alanine mutation of the 14-3-3 consensus sites,
leads to nuclear accumulation and increased repressive activity.
This suggests that modulation of class IIa HDAC phosphorylation
would provide the unique opportunity to control their biological
functions. Indeed, activation of class IIa HDAC target genes can
be achieved by overexpression of protein kinases or inhibition of
protein phosphatase, each leading to hyperphosphorylation and
cytoplasmic accumulation of class IIa HDACs. A great deal of
effort has thus been invested in identifying the protein kinases and
phosphatases targeting class IIa HDAC 14-3-3 motifs. To date,
four families of serine/threonine kinases and two families of
phosphatases have been implicated in this mechanism. Histori-
cally, members of the Ca2+/calmodulin-dependent kinase family
(CaMK), specifically CaMKI and IV, were the first kinases shown
to promote 14-3-3 binding and nuclear export of class IIa HDACs.
Functional relevance of these findings was provided in various
biological contexts in which activation of CaMK members corre-
lates with activation of class IIa HDAC targets genes (Backs et al.,
2006; Bossuyt et al., 2008; Chawla et al., 2003; Davis et al., 2003;
Grozinger and Schreiber, 2000; Kao et al., 2001; Karamboulas et
al., 2006b; Linseman et al., 2003; Lu et al., 2000b; McKinsey et al.,
2000b). However, these studies mainly rely on overexpression or
pharmacological inhibition of CaMK and remain to be validated by
more definite loss-of-function approaches. More recently, protein
kinase D (PKD), a downstream effector of PKC was shown to
phosphorylate the 14-3-3 binding sites of class IIa HDACs and
neutralize their repressive activity (Dequiedt et al., 2005; Matthews
et al., 2006; Parra et al., 2005; Vega et al., 2004a). Convincing
experimental evidence have demonstrated that PKD activation is
necessary for inactivation of class IIa HDACs during T-cell apo-
ptosis (Dequiedt et al., 2005; Parra et al., 2005), cardiac hypertro-
phy (Bossuyt et al., 2008; Vega et al., 2004a), B-cell receptor
signaling (Matthews et al., 2006), skeletal and cardiac muscle
remodeling (Fielitz et al., 2008; Kim et al., 2008a) and angiogen-
esis (Ha et al., 2008; Wang et al., 2008). Mice with reduced CREB
activity develop muscular dystrophy because of increased ex-
pression of salt-inducible kinase 1 (SIK1). Interestingly these
mice also exhibit hyperphosphorylation of HDAC5, suggesting
that SIK1 could be a class IIa HDAC kinase. Indeed loss- and
gain-of-function studies demonstrated that SIK1 phosphorylates
the 14-3-3 binding sites of HDAC5, revealing an important CREB-
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SIK1-HDAC5-MEF2 axis in the regulation of the myogenic pro-
gram (Berdeaux et al., 2007; Takemori et al., 2009). However,
whether this pathway is also conserved in other MEF2-regulated
programs remains totally unexplored. In addition to the signal-
regulated protein kinases described above, two members of the
microtubule affinity-regulating kinase (MARK)/Par-1 family, which
are usually considered as constitutively active kinases (Lizcano et
al., 2004), were shown to directly phosphorylate and promote
nuclear export of class IIa HDACs (Chang et al., 2005; Dequiedt
et al., 2006). Unfortunately, despite strong biochemical data
these studies lack supporting evidence to demonstrate the bio-
logical relevance of their findings.
Considering the reversible nature of protein phosphorylation,
protein phosphatases should be as important as protein kinases
in the regulation of class IIa HDACs. Indeed, Parra et al. recently
reported dephosphorylation of HDAC7 by the myosin phos-
phatase complex, which contains PP1β and myosin phosphatase
targeting subunit 1 (MYPT1) (Parra et al., 2007). In addition,
results from our laboratory and others have revealed that another
cellular phosphatase, PP2A, stably associates with and constitu-
tively dephosphorylates class IIa HDACs in vivo (Martin et al.,
2008; Paroni et al., 2008). Accordingly, PP2A participates in the
regulation of class IIa HDAC subcellular localization and directly
impacts on their biological functions (Illi et al., 2008; Martin et al.,
2008; Paroni et al., 2008; Sucharov et al., 2006). The sequential
and/or coordinated actions of these multiple protein kinases and
phosphatases would constitute a tightly regulated mechanism
allowing appropriate, rapid, and reversible expression of class IIa
HDAC target genes in response to specific developmental sig-
nals.
In addition to phosphorylation of their 14-3-3 binding sites,
(Chen et al., 2006). Similarly, miR140, a cartilage specific miRNA,
can bind to HDAC4 mRNA and interfere with its translation
(Tuddenham et al., 2006). Unfortunately, the biological relevance
of these findings during bone development was not investigated.
Nonetheless, these important studies opened a new line of
investigation in the regulation of class IIa HDACs which deserves
to be explored in the context of other class IIa HDACs-regulated
developmental programs.
The existence of multiple regulatory pathways converging on
class IIa HDACs emphasizes the importance of these enzymes in
various biological processes. In the past 5 years, genetic inacti-
vation studies in mice conducted by the Olson laboratory have
been instrumental in elucidating the biological functions of these
enzymes. These studies have revealed the key role of class IIa
members in several important developmental and differentiation
processes. Surprisingly, despite the large number of transcrip-
tional regulators targeted by class IIa HDACs, most of their
functions seem to involve the transcriptional repression of MEF2
transcription factors (Fig. 1). In the following sections, we will
review the latest insights into the biological functions of these
fascinating enzymes.
Chondrocyte hypertrophy
HDAC4-null mice die during the perinatal period due to severe
growth retardations and numerous skeletal abnormalities that
result from excessive hypertrophic chondrocyte differentiation
and inadequate endochondral ossification (Vega et al., 2004b).
This remarkable phenotype was originally attributed to the ability
of HDAC4 to repress Runt-related transcription factor-2 (Runx2),










Myoblast Differentiation Muscle Activity
Neuron Survival
Fig. 1. Central role of MEF2 in the biological functions of class IIa HDACs. Gene
targeting studies in mice have revealed tissue specific functions for each member
of the class IIa HDACs. HDAC4-null mice display inappropriate chondrocyte hyper-
trophy whereas mice lacking HDAC7 die from cardiovascular defects and mutant
mice for HDAC5 and HDAC9 develop spontaneous cardiac hypertrophy. Surpris-
ingly, the known biological functions of class IIa HDACs have been associated with
repression of the MEF2 family of transcription factors. A similar class IIa HDACs-
MEF2 axis could be involved in cardiac muscle development, skeletal muscle
differentiation and remodelling and T-cell apoptosis.
class IIa HDACs are subject to additional posttransla-
tional modifications: phosphorylation/dephosphorylation
at serine residues distinct from the 14-3-3 binding sites
(Deng et al., 2005; Paroni et al., 2008; Zhou et al., 2000b),
sumoylation (Kirsh et al., 2002; Petrie et al., 2003; Tatham
et al., 2001), ubiquitination (Hook et al., 2002) and caspase
cleavage (Li et al., 2004; Paroni et al., 2004; Scott et al.,
2008). For more details on how these modifications
impact on localization, stability, repressive or catalytic
activity of specific members of class IIa HDACs, we
respectfully refer the reader to recently published re-
views (Martin et al., 2007; Yang and Seto, 2008).
Recently, two additional mechanisms of class IIa
HDACs regulation have been documented. First, HDAC4
was shown to oligomerize with HDAC5, and to a lesser
extent with HDAC9. Interestingly, amongst the class IIa
HDACs, HDAC4 is uniquely sensitive to CaMKII-medi-
ated phosphorylation and nuclear export (Backs et al.,
2006). Hetero-oligomerization with HDAC4 brings HDAC5
in close proximity of CaMKII, allowing its phosphorylation
by the kinase and promoting its nuclear export (Backs et
al., 2008). Whether this transphosphorylation mecha-
nism also exists for other class IIa HDACs and as-yet-
unidentified specific kinases remains unknown. In addi-
tion, two studies recently reported that expression of
HDAC4 is regulated at the post-transcriptional level by
microRNAs (miRNA). During skeletal muscle differentia-
tion, miR-1 promotes myogenesis by targeting HDAC4
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(Komori et al., 1997; Otto et al., 1997). Indeed, HDAC4 physi-
cally associates with Runx2 and inhibits its transcriptional
activities. In addition, the phenotypic abnormalities of HDAC4
KO mice are strikingly reminiscent of those observed in mice
with ectopic expression of Runx2 in prehypertrophic chondro-
cytes (Takeda et al., 2001; Ueta et al., 2001). The precise
mechanism by which HDAC4 inhibits Runx2-mediated tran-
scription remains obscure. Original observations suggested
that repression of Runx2 by HDAC4 might occur independently
of its HDAC catalytic activity. Instead, HDAC4 was thought to
impede on Runx2 DNA binding by direct association with its
Runt domain (Vega et al., 2004b). However this model failed to
explain why HDAC4 mutants consisting of the C-terminal cata-
lytic domain of HDAC4, and thus lacking the Runx2 binding
region, retain significant repressive activity. The recent obser-
vation that HDAC4 and HDAC5 deacetylate Runx2 and Runx3
provides an explanation for these apparent discrepancies (Jeon
et al., 2006; Jin et al., 2004). In addition to preventing Runx2
from binding to DNA, HDAC4 may deacetylate Runx2 and
promote its ubiquitin-mediated degradation. This double-tar-
geting of Runx2 by HDAC4 would thus solely explain its key role
as a negative regulator of chondrocyte hypertrophy.
This apparently satisfying model was recently challenged by
a study published by the same authors and which unravelled
the unexpected role of MEF2C in chondrocyte hypertrophy
(Arnold et al., 2007). This study reports that homo- or even
heterozygous mutation of Mef2c is associated with severe
skeleton defects resulting from reduced chondrocyte hypertro-
phy and ossification of endochondral bones. Given the prepon-
derance of the class IIa HDACs-MEF2 axis in several develop-
mental programs (see below), this unexpected finding raises
the possibility that bone defects associated with deletion of
Hdac4 could, at least partly, result from hyperactivation of
MEF2C. Supporting this hypothesis, a genetic antagonism
exists between HDAC4 and MEF2: the excessive endochondral
ossification observed in HDAC4 null mice is partially abolished
by deletion of one Mef2c allele. Conversely, inactivation of
Hdac4 in the presence of a heterozygous Mef2c allele partially
restored normal endochondral ossification. Interestingly, ex-
pression of Runx2 was greatly diminished in the endochondral
cartilage of Mef2c mutant mice, indicating that some of the
defects associated with Mef2c deficiency may be mediated by
reduced Runx2 activity. By controlling key transcriptional regu-
lators of chondrocyte hypertrophy, it is thus clear that HDAC4
plays a central role in the control of bone development. Interest-
ingly, Runx2 is involved at multiple stages of bone develop-
ment, such as osteoblast differentiation (Komori, 2008). Using
in vitro models, HDAC7 was recently identified as a negative
regulator of osteoblast differentiation through its Runx2 co-
repressor function (Jensen et al., 2008). In addition, HDAC4
and HDAC5 have been shown to participate in the repression of
Runx2 by Smad3 during osteoblast differentiation (Kang et al.,
2005). While HDAC4 and -5 are expressed at significant levels
in mesenchymal cells and osteoblasts, no evidence for HDAC7
expression in this cell lineage has been reported. In addition,
the severe skeletal defects associated with HDAC4 deficiency
were not observed in other class IIa HDACs mutant mice and
could imply a specific role for HDAC4 as a negative regulator of
bone development. A more careful examination of bone devel-
opment in mice lacking class IIa HDACs should unravel any
functional overlap that may exist between these proteins.
Myogenesis
Skeletal muscle differentiation
Formation of skeletal muscle involves commitment of multipo-
tential mesodermal precursor cells to the muscle lineage and their
proliferation as myoblasts. Upon mitogens withdrawal, proliferat-
ing myoblasts exit the cell cycle and differentiate into multinucle-
ated muscle fibers. The myogenic process results from a specific
genetic program, with activation of hundreds of muscle-specific
genes and repression of genes associated with cell proliferation.
MEF2 has long been known as a key transcriptional regulator of
skeletal muscle differentiation. Logically, the functional associa-
tion between MEF2 family members and class IIa HDACs was
originally tested in the context of myogenesis (Wang et al., 1999;
Miska et al., 1999; Lu et al., 2000a; Lemercier et al., 2000). In vitro,
class IIa HDACs negatively regulate muscle differentiation through
association with MEF2 and repression of its target genes (Dressel
et al., 2001; Haberland et al., 2007; Lu et al., 2000b). In addition,
the inhibitory action of class IIa HDACs can be overcome by
myogenic signals that disrupt MEF2–HDAC interactions and
stimulate nuclear export of these transcriptional repressors dur-
ing muscle differentiation (McKinsey et al., 2002). Surprisingly,
normal overall skeletal muscle differentiation was maintained in
mice mutated in each individual class IIa HDAC. This apparent
discrepancy might result from the partial functional overlap that
may exist between class IIa HDAC members. However, several
observations indicate that the functional redundancy observed
between class IIa HDACs in vitro may not exist in vivo. Indeed,
class IIa members show distinct subcellular localizations in muscle
cells. HDAC4 is mainly cytoplasmic in undifferentiated myoblasts
and accumulates in the nucleus upon differentiation into myotubes,
(Miska et al., 2001). In contrast, HDAC5 and HDAC7 relocate
from the nucleus to the cytoplasm as myoblasts differentiate into
myotubes (Dressel et al., 2001; McKinsey et al., 2000a). These
findings suggest that class IIa HDACs respond differently to
physiologic stimuli and could thus have distinct roles during
skeletal muscle differentiation.
Skeletal muscle remodelling
Skeletal muscle of adult vertebrates consists of type I and type
II myofibers, which differ with respect to size, metabolism and
contractile function. Slow-twitch or type I myofibers exhibit an
oxidative metabolism and are resistant to fatigue, while in con-
trast, fast-twitch or type II fibers use glycolytic metabolism, fatigue
rapidly and are involved in rapid bursts of activity. Numerous
stimuli modulate skeletal muscle phenotype and induce switch
from one specialized myofiber type to the other. MEF2 is prefer-
entially activated in slow, oxidative myofibers (Wu et al., 2000)
and activates the slow myofiber gene program (Potthoff et al.,
2007). Logically, class IIa HDACs were recently implicated in the
regulation of myofiber identity. In slow or oxidative fibers, class IIa
HDACs are selectively degraded through a proteasome-depen-
dent pathway. This specific degradation of class IIa HDACs
alleviates their repression over MEF2, and probably other uniden-
tified transcription factors allowing the induction of a slow skeletal
muscle specific gene program. Mice lacking individual class IIa
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HDACs in their skeletal muscle did not display abnormalities in
fiber-type switching. However deletion of any combination of 4
alleles of Hdac4, -5, or -9 results in enhanced slow-fiber gene
expression and increased percentage of slow myofibers, reveal-
ing functional redundancy between class IIa members. Interest-
ingly, overexpression of constitutively active forms of PKD and
CaMKIV, in adult glycolytic fibers of transgenic mice results in an
increase in the number of slow fibers and enhances muscle
oxidative capacity (Kim et al., 2008a; Wu et al., 2002). Because
previous studies have established that these kinases stimulate
MEF2 activity by promoting the phosphorylation and export of
class II HDACs from the nucleus (Martin et al., 2007), these
observations further support a role for class IIa HDACs in fiber
type specification.
In response to variations in environmental and functional
demands, skeletal muscle adapt by remodelling the biochemical,
morphological, and physiological states of individual myofibers
(Bassel-Duby and Olson, 2006). These changes involve activa-
tion of intracellular signalling pathways and consequent genetic
reprogramming, resulting in alterations of muscle mass, contrac-
tile properties, and metabolic states. Numerous stimuli, such as
exercise, electrical stimulation or microgravity can induce muscle
remodelling. Neuron-induced electrical activity has been known
for a long time to induce specific transcriptional reprogramming of
muscle and several neural activity-responsive genes have been
identified. A typical example is the nicotinic acetylcholine recep-
tors (AChRs), whose expression is highly sensitive to muscle
innervation. AChR expression relies on the basic helix-loop-helix
(bHLH) myogenic transcription factor myogenin. After innerva-
tion, neuron-induced electrical activity induces active transcrip-
tional repression of myogenin throughout the muscle, which
coincides with decreased extra-synaptic AChR expression lev-
els. Recently, class IIa HDACs have been directly implicated in
the regulation of myogenin expression. In innervated muscle,
MITR, the non catalytic isoform of HDAC9, is highly expressed
and represses transcription of myogenin through inhibition of
MEF2. Conversely, denervation induces dramatic transcriptional
downregulation of MITR, which correlates with subsequent
myogenin and AChR expression (Mejat et al., 2005). Interest-
ingly, the observation that a MITR mutant protein lacking the
MEF2-interacting domain retains 50% inhibitory activity on the
expression of AChR and myogenin suggests that MITR could
have additional targets besides MEF2. HDAC9-null mice do not
show any obvious perturbation of skeletal muscle function under
normal conditions but were sensitized to denervation. This sensi-
tized phenotype is reminiscent of the cardiac phenotype observed
in HDAC5 and HDAC9- null mice and establishes class IIa HDACs
as general stress sensors and integrators.
Besides MEF2, Dash2, a Dachschund related transcriptional
co-repressor whose expression is decreased upon denervation,
was reported to inhibit myogenin expression in innervated muscle
(Tang and Goldman, 2006). In contrast to MITR/HDAC9, HDAC4
expression is highly induced in response to denervation, suggest-
ing that both class IIa HDACs could have opposite effects in
denervation-induced nAChR expression (Cohen et al., 2007).
This model is supported by the observation that neuronal input
also induces nuclear accumulation of HDAC4 (Liu et al., 2005). In
the nucleus, HDAC4 associates with the Dach2 promoter and
thus activates the myogenin/AChR cascade through active down-
regulation of Dach2. Unexpectedly, the opposite regulations of
HDAC4 and MITR by neuronal activity lead to the same transcrip-
tional outcome: induction of myogenin/AChR expression by den-
ervation. The most interesting corollary to these observations is
that these two class IIa members must impede on the neuronal
activity-dependent transcriptional reprogramming of muscle
through non-redundant, complementary pathways. Whether similar
combinatorial regulation by multiple class IIa members also exists
for other transcriptional programs involving class IIa HDACs
needs to be investigated.
Cardiac muscle development
Heart formation is initiated from the mesoderm in vertebrate
embryos. The first stage of cardiomyogenesis involves the forma-
tion of cardiomyoblasts, which express a distinct subset of tran-
scription factors, including MEF2C, the homeobox transcription
factor Nkx2-5 and members of the cardiac GATA subfamily
(Zaffran and Frasch, 2002). These factors activate the expression
of cardiac-muscle-specific genes to form the differentiated cardi-
omyocytes. Overexpression of HDAC4, or inhibition of the inacti-
vating class IIa HDAC kinase CaMK, was shown to inhibits the
transition from mesoderm to cardiomyoblast during
cardiomyogenesis in P19 cells (Karamboulas et al., 2006b).
Surprisingly, mice mutated for individual class IIa HDACs do not
exhibit obvious abnormalities of the hearth. In contrast, HDAC5/
9 double mutant mice are prone to perinatal death from ventricular
septum defects and thin ventricular walls, which typically originate
from abnormalities in growth and maturation of cardiomyocytes
(Chang et al., 2004). Whereas the molecular mechanisms under-
lying the role of class IIa HDACs in these processes remain
obscure, studies in mice and Drosophila have established the
importance of MEF2 in the control of cardiac muscle differentia-
tion (Bour et al., 1995; Karamboulas et al., 2006a; Lilly et al., 1995;
Lin et al., 1997; Ranganayakulu et al., 1995). It is thus likely that
at least part of the cardiomyogenesis defects associated with
class IIa HDACs inactivation arise from superactivation of MEF2
transcriptional activity. However, it is also possible that class IIa
HDACs directly or indirectly repress other transcription factors
that are important for cardiomyogenesis, such as SRF, CAMTA,
Nkx2-5, myocardin and GATA factors (Davis et al., 2003; Han et
al., 2006; Long et al., 2007; Song et al., 2006).
Cardiac hypertrophy
Cardiac hypertrophy, which is defined as an increase in
cardiomyocyte size and reactivation of a specific fetal cardiac
gene program, is an adaptive response of the heart to a variety of
stress stimuli. Stress-induced hypertrophy may initially normalize
ventricular wall stress, but excessive hypertrophic growth of the
heart frequently leads to maladaptive changes that ultimately
weakens cardiac performance and can lead to heart failure
(Backs and Olson, 2006; Hill and Olson, 2008).
Transcripts for every class IIa HDACs, including the splicing
HDAC9 variant MITR are found at high levels in mouse heart
(Zhang et al., 2002). In addition, ectopic expression of constitu-
tively repressive mutants of HDAC4, -5 and -9 (i.e. mutants
insensitive to signal-responsive class IIa HDAC kinases) sup-
press hypertrophy of primary cardiomyocytes and expression of
fetal cardiac genes in vitro (Backs et al., 2006; Vega et al., 2004a;
Zhang et al., 2002). Gene-inactivation studies in mice have
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provided definite evidence of the importance of class IIa HDACs
as signal-responsive suppressors of postnatal cardiac growth.
HDAC5 or HDAC9-KO mice exhibit no evidence of cardiac abnor-
malities during the early post-natal period. However, within their
first year, these mutant mice develop spontaneous cardiac hyper-
trophy, which appears to result form hypersensitivity to age-
related cardiac stress. HDAC5 and HDAC9 mutant mice also
show exacerbated hypertophic response to pressure overload or
constitutive activation of calcineurin (Chang et al., 2004; Zhang et
al., 2002). The remarkably similar cardiac phenotypes observed
in HDAC5 or HDAC9 mutant mice suggest that these two class IIa
members play redundant roles in the control of the same patho-
logical hypertrophy signalling pathways. Unfortunately, mice lack-
ing either HDAC4 or HDAC7 are not viable, which has precluded
from investigating the potential involvement of these class IIa
members in cardiac hypertrophy (Chang et al., 2006; Vega et al.,
2004b). Conditional gene deletion studies will be needed to test
whether HDAC4 and HDAC7 play functional roles similar to that
of HDAC5 and HDAC9 in the cardiac pathologic response.
MEF2, and in particular MEF2D plays an important role as an
integrator and mediator of stress-dependent remodelling of the
adult heart (Kim et al., 2008b; Lu et al., 2000a; Nadruz et al.,
2003). Indeed, Mefd2d-null mice display impaired cardiac hyper-
trophic response to pressure overload and adrenergic signalling
(Kim et al., 2008b). Hypertrophic cardiac growth in HDAC5 or
HDAC9 mutant mice correlates with superactivation of MEF2,
suggesting that MEF2 is the critical target of class IIa HDACs in
specific signalling pathways leading to cardiac hypertrophy. In-
deed, while inactivation of Mef2d alleles renders mice resistant to
cardiac remodelling in response to β-adrenergic stimulation,
HDAC5 or HDAC9-null mice respond normally to isoproterenol
stimulation (Chang et al., 2004; Kim et al., 2008b). This interesting
observation could indicate that only specific signalling pathways
of cardiac hypertophy involve class IIa HDAC-mediated regula-
tion of MEF2. On the other hand, the insensitivity of mice lacking
either HDAC5 or HDAC9 to adrenergic stimuli could suggest a
functional redundancy with other class IIa members in this par-
ticular pathway. Identification of the precise role and specific
physiological relevant targets of each class IIa HDAC in cardiac
hypertrophy will help solving these important issues.
Neuronal survival
HDAC4 and HDAC5 mRNA are highly abundant in the brain
suggesting a role for these class IIa members in neurons (Grozinger
et al., 1999). HDAC4 is predominantly cytoplasmic in cerebellar
granule neurons (CGNs), and signals promoting its nuclear trans-
location or expression of constitutively nuclear mutants correlates
with apoptosis (Bolger and Yao, 2005). Similarly, HDAC5 is
mainly cytoplasmic in CGNs cultured under depolarizing condi-
tions. Switching CGNs to non-depolarizing medium, which in-
duces cytoplasm-to-nucleus translocation of HDAC4 and -5,
correlates with induction of apoptosis (Linseman et al., 2003).
MEF2 is a well-established survival factor in neurons (Mao et al.,
1999) and as expected, induction of apoptosis by HDAC4 and -5
correlates with repression of MEF2 transcriptional activity (Bolger
and Yao, 2005; Linseman et al., 2003). However, whether HDAC4
and/or HDAC5 target any other transcription factor besides MEF2
remains to be explored. Interestingly, HDAC4 appears to have a
more predominant role in neuronal cell death, as siRNA-medi-
ated inhibition of HDAC4 efficiently suppresses neuronal death,
arguing against functional redundancy between HDAC4 and
HDAC5 (Bolger and Yao, 2005). In addition, HDAC5 knock-
down mice showed no obvious brain defects, whereas mice
lacking HDAC4 have abnormal shaped brains and exencephaly,
probably resulting form precocious ossification of the brain
(Vega et al., 2004b). However, more careful examination of
HDAC4-null mice revealed delay in the formation of folia,
suggesting a pro-survival rather than a pro-apoptotic role for
HDAC4 (Majdzadeh et al., 2008; Vega et al., 2004b). Indeed, a
recent study reported that HDAC4 prevents low-potassium
induced neuronal cell death, through inhibition of activity of
cyclin-dependent kinase-1 (CDK1). Supporting their results,
the authors described higher CDK1 activity in the brain of
HDAC4-/- mice (Majdzadeh et al., 2008). Similarly, studies
using a model of mouse retina degeneration showed that
HDAC4 promotes survival of photoreceptor cells (Chen and
Chepko, 2009). Interestingly, this pro-survival function of HDAC4
was associated with its presence in the cytoplasm and might
thus be independent of its nuclear repressive function. The
reasons for these contradictory results remain unclear and
should instigate further studies about the role of class IIa
HDACs in neurons.
Immune cells
After entering the thymus, precursor T-cells differentiate into
mature lymphocytes following a complex and highly regulated
process (Ciofani and Zuniga-Pflucker, 2007). Complete matu-
ration of developing thymocytes implies that they successfully
pass a series of developmental checkpoints. After complete
rearrangement of their T-cell receptor (TCR) chains, thymocytes
become CD4+/CD8+, or double-positive (DP) thymocytes and
undergo negative and positive selection. During these pro-
cesses, their TCR is tested for its ability to interact with self-
peptide bound to major histocompatibility complex (MHC) mol-
ecules of the thymic antigen-presenting cells (APCs). Positive
selection will only allow further differentiation of thymocytes
carrying a functional TCR. Potentially autoreactive thymocytes
bearing TCR with strong affinity to MHC-self peptide complexes
are deleted by the apoptotic process of negative selection. The
different developmental fates of maturing thymocytes are dic-
tated by the integration of various signals and the translation of
these signals into changes in gene expression.
In human, HDAC7 is highly expressed in thymus, heart and
lung. Within the thymus, we have shown that HDAC7 is tran-
siently and predominantly expressed in CD4/CD8 DP thy-
mocytes (Dequiedt et al., 2003). Consistent with this, HDAC7
associates with MEF2D and represses the expression of a
series of MEF2-target genes involved in negative and positive
selections, such as the pro-apoptotic orphan nuclear receptor
Nur77 (Dequiedt et al., 2003; Kasler and Verdin, 2007). The
release of HDAC7-mediated repression is achieved through a
complex signalling cascade. Engagement of the TCR by MHC-
self peptides results in dissociation of HDAC7-MEF2D com-
plexes, phosphorylation and cytoplasmic accumulation of
HDAC7 which ultimately leads to de-repression of MEF2-target
genes (Dequiedt et al., 2005). Interestingly, microarray-based
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analysis has revealed that HDAC7 could regulate both MEF2-
dependent and independent genes (Kasler and Verdin, 2007).
However, how HDAC7 regulates transcription independently of
MEF2 was not investigated. Amongst the MEF2-HDAC7 regu-
lated genes in thymocytes, this study also identified HDAC5,
which could suggest a role for this class IIa member during T-
cell differentiation.
In B cells, signalling from the B-cell antigen receptor has
been shown to regulate HDAC5 and HDAC7 phosphorylation,
localization and repressive function (Matthews et al., 2006).
Even if chemical inhibition of HDACs supports a role for HDACs
in B-cell differentiation and survival, the transcriptional targets
and functional significance of these findings remain currently
unknown.
Vascularisation
Early studies using general HDAC inhibitors suggested the
possible implication of zinc-dependent HDACs in the transcrip-
tional control of endothelial gene expression and vascular
development (Kim et al., 2001; Kwon et al., 2002). However,
until recently, definite experimental evidence about the function
of class I and class II HDACs in these processes was lacking.
In situ hybridization studies revealed specific expression of
HDAC7 in the vascular endothelium during mouse embryogen-
esis. Consistent with this, inactivation of the HDAC7 gene in a
ubiquitous or endothelial specific manner had dramatic conse-
quences on vascular integrity, with mutant mice dying in utero
from blood vessel dilatations, ruptures and haemorrhages. In
addition, siRNA-mediated inactivation of HDAC7 in human
umbilical vein endothelial cells (HUVECs) prevents formation
of capillary-like structures in vitro (Chang et al., 2006). Microarray
analysis revealed that HDAC7 regulates the expression of
several genes encoding extracellular matrix and adhesion pro-
teins, among which the secreted matrix metalloprotease 10
(MMP-10). Regulation of MMP-10 expression by HDAC7 relies
on its association with MEF2C, a factor implicated in blood
vessel development and vascular integrity (Lin et al., 1998),
and constitutes yet another example in which the class IIa
HDACs-MEF2 axis controls an important genetic developmen-
tal program. Inappropriate expression of MMP10 in HDAC7-
null mice would be expected to disrupt endothelial cell-cell
adhesion and could thus explain the defects associated with
HDAC7 inactivation. However, a more recent study has brought
some new light on the role of HDAC7 during angiogenesis and
vascularisation. Using a complete set of in vitro assays, Mottet
and colleagues have shown that the inability of HDAC7-si-
lenced HUVECs to assemble into tube-like structures in vitro
could result from alterations of their motility (Mottet et al., 2007).
In addition, HDAC7 silencing correlates with increased expres-
sion of PDGF-B, a regulator of migration and tubulogenesis of
endothelial cells (De Marchis et al., 2002). Even though the
molecular mechanisms underlying the transcriptional control of
PDGF-B by HDAC7 are unknown, these findings raise the
appealing possibility that HDAC7 might regulate multiple stages
during vasculature formation. Interestingly, HDAC7 silencing
was also associated with altered morphology of the cells, which
could also impact on their angiogenic properties (Holderfield
and Hughes, 2008). Considering its potential impact on multiple
aspects of vasculogenesis, identification of HDAC7 target genes
has become a necessary step toward a better understanding of
vascular development.
Future prospects
As described above, the past 5 years have witnessed the
emergence of class IIa HDACs as key regulators in several
important biological processes. Through their signal-responsive
regulation and their ability to repress the transcriptional activity of
numerous transcription factors, class IIa HDACs integrate and
translate extracellular signals into specific genetic activation
programs. Recent studies in mice deficient for each class IIa
member have corroborated this model and revealed major de-
fects in important developmental programs such as embryonic
bone formation and vascularisation and cardiac hypertrophy (see
above). While groundbreaking, these studies have focused on the
functions of class IIa HDACs leading to the most spectacular
phenotypical defects. However, the early observation that class
IIa HDACs are expressed in multiple tissues suggests that they
might have several biological functions, depending on the cellular
context. More careful examination of class IIa HDAC null-mice
should identify less obvious phenotypical defects and therefore
suggest additional biological functions for these enzymes. For
instance, while HDAC4-deficient mice die perinatally from skel-
etal defects, demonstrating the key role of this class IIa member
in bone development, they also exhibit cerebellar abnormalities
which could support a role for HDAC4 in neuronal survival
(Majdzadeh et al., 2008).
Surprisingly, and despite the fact that they can associate with
a plethora of partners, the biological functions of class IIa HDACs
seem to rely almost uniquely on their association with MEF2
transcription factors. MEF2 has been implicated in a myriad of
developmental, physiological and pathological processes, each
of which could potentially be regulated by a class IIa HDACs-
MEF2 axis. Amongst the MEF2-regulated processes, the unique
or redundant in vivo functions of class IIa members remain to be
investigated in contractile myofibril assembly (Hinits and Hughes,
2007), craniofacial development (Verzi et al., 2007), postsynaptic
morphogenesis and brain development (Shalizi et al., 2006;
Shalizi and Bonni, 2005). Inversely, several lines of experimental
evidence suggest that class IIa HDACs can regulate transcription
independently of MEF2 (Kasler and Verdin, 2007). Nonetheless,
whether MEF2-independent biological functions exist for class IIa
HDACs remains an unanswered question and deserves to be
thoroughly adressed. The existing studies about the in vivo
functions of class IIa HDACs have overlooked the many other
transcriptional targets of these enzymes and often linked the
observed physiological defects with hyperactivation of MEF2.
The existence of knock-out mice for each class IIa HDAC member
gives now the opportunity to validate additional known class IIa
HDAC partners besides MEF2.
Functional inactivation of class IIa HDACs via signal-depen-
dent phosphorylation and nuclear export has been extensively
illustrated in in vitro systems (Martin et al., 2007). This mechanism
is now being validated in vivo by recent studies showing the
importance of known class IIa HDAC kinases in cardiac hypertro-
phy (Backs et al., 2006; Fielitz et al., 2008; Harrison et al., 2006)
and skeletal muscle function and remodeling (Kim et al., 2008a).
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Logically, class IIa HDAC kinases should also be involved in other
class IIa HDAC regulated genetic programs such as chondro-
cytes hypertrophy, neuron and immune cells apoptosis (Dequiedt
et al., 2005; Parra et al., 2005), and blood vessel development
(Harrison et al., 2006).
The establishment of class IIa HDACs as key modulators of
various differentiation and developmental programs, especially in
pathological related processes, potentially offers new therapeutic
strategies for various human diseases. A still limited number of
studies have reported alterations of class IIa HDACs in several
cancers (Chaabouni et al., 2006; Ouaissi et al., 2008; Ozdag et
al., 2006; Yuki et al., 2004) and neuronal disorders (Hoshino et al.,
2003; Iga et al., 2007; Renthal et al., 2007). Armed with the new
insights into their regulation and biological functions, it seems
possible to specifically modulate class IIa HDAC activity and
normalize pathological gene expression patterns in disorders
such as cardiac hypertrophy, hearth failure, tumour growth or
skeletal muscle wasting.
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